发明授权
US5980933A Transdermal formulation of xanomeline 失效
xanomeline的透皮制剂

Transdermal formulation of xanomeline
摘要:
The present invention provides a method for treating Alzheimer's Disease using a xanomeline transdermal formulation. The invention provides desired transdermal xanomeline patch formulations.
公开/授权文献
信息查询
0/0